144 related articles for article (PubMed ID: 15294968)
1. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses.
Kim AH; Dimitriou ID; Holland MC; Mastellos D; Mueller YM; Altman JD; Lambris JD; Katsikis PD
J Immunol; 2004 Aug; 173(4):2524-9. PubMed ID: 15294968
[TBL] [Abstract][Full Text] [Related]
2. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
Vadrevu SK; Chintala NK; Sharma SK; Sharma P; Cleveland C; Riediger L; Manne S; Fairlie DP; Gorczyca W; Almanza O; Karbowniczek M; Markiewski MM
Cancer Res; 2014 Jul; 74(13):3454-65. PubMed ID: 24786787
[TBL] [Abstract][Full Text] [Related]
3. The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity.
Marois I; Cloutier A; Garneau É; Lesur O; Richter MV
FASEB J; 2015 Mar; 29(3):973-87. PubMed ID: 25414485
[TBL] [Abstract][Full Text] [Related]
4. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.
Song N; Li P; Jiang Y; Sun H; Cui J; Zhao G; Li D; Guo Y; Chen Y; Gao J; Sun S; Zhou Y
Int Immunopharmacol; 2018 Jun; 59():12-20. PubMed ID: 29621732
[TBL] [Abstract][Full Text] [Related]
5. Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice.
Kambayashi T; Assarsson E; Michaëlsson J; Berglund P; Diehl AD; Chambers BJ; Ljunggren HG
J Immunol; 2000 Nov; 165(9):4964-9. PubMed ID: 11046023
[TBL] [Abstract][Full Text] [Related]
6. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV.
Jiang Y; Zhao G; Song N; Li P; Chen Y; Guo Y; Li J; Du L; Jiang S; Guo R; Sun S; Zhou Y
Emerg Microbes Infect; 2018 Apr; 7(1):77. PubMed ID: 29691378
[TBL] [Abstract][Full Text] [Related]
8. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections.
Hogan RJ; Usherwood EJ; Zhong W; Roberts AA; Dutton RW; Harmsen AG; Woodland DL
J Immunol; 2001 Feb; 166(3):1813-22. PubMed ID: 11160228
[TBL] [Abstract][Full Text] [Related]
9. Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-β1 in Gr-1+ myeloid cells.
Qing X; Koo GC; Salmon JE
Eur J Immunol; 2012 Jul; 42(7):1723-34. PubMed ID: 22535677
[TBL] [Abstract][Full Text] [Related]
10. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection.
Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
Eur J Immunol; 2001 May; 31(5):1523-30. PubMed ID: 11465109
[TBL] [Abstract][Full Text] [Related]
11. Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8(+) T cell proliferation, but does not account for the CD4(+) T cell independence of the CD8(+) T cell response during influenza virus infection.
Oh S; Belz GT; Eichelberger MC
Virology; 2001 Aug; 286(2):403-11. PubMed ID: 11485408
[TBL] [Abstract][Full Text] [Related]
12. Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.
Nitta H; Murakami Y; Wada Y; Eto M; Baba H; Imamura T
Oncol Rep; 2014 Oct; 32(4):1715-9. PubMed ID: 25050844
[TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza.
Lund FE; Partida-Sánchez S; Lee BO; Kusser KL; Hartson L; Hogan RJ; Woodland DL; Randall TD
J Immunol; 2002 Nov; 169(9):5236-43. PubMed ID: 12391242
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
[TBL] [Abstract][Full Text] [Related]
15. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
16. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
Bertram EM; Lau P; Watts TH
J Immunol; 2002 Apr; 168(8):3777-85. PubMed ID: 11937529
[TBL] [Abstract][Full Text] [Related]
17. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
La Gruta NL; Turner SJ; Doherty PC
J Immunol; 2004 May; 172(9):5553-60. PubMed ID: 15100298
[TBL] [Abstract][Full Text] [Related]
18. Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation.
Raedler H; Yang M; Lalli PN; Medof ME; Heeger PS
Am J Transplant; 2009 Aug; 9(8):1784-95. PubMed ID: 19563342
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo.
Dolfi DV; Duttagupta PA; Boesteanu AC; Mueller YM; Oliai CH; Borowski AB; Katsikis PD
J Immunol; 2011 Apr; 186(8):4599-608. PubMed ID: 21389258
[TBL] [Abstract][Full Text] [Related]
20. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
